Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
LATEST IN amyloid-β protein
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
Chemistry Professor Michael Nichols discusses his research on Alzheimer’s disease as part of NextGen Precision Health’s Discovery Series
Nichols has been studying how the amyloid-β protein interacts with a group of three proteins known as NLRP3 inflammasome to cause inflammation inside immune cells in the brain.
At the Missouri Arts Council, Bob Madden helps foster community engagement and education through art
Madden works to strengthen arts education in Missouri and make art more accessible to non-profits and communities across the state.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
CLIMB program celebrates 10th class of summer interns
A total of four students from Hazelwood East High School, Hazelwood West High School and University City High School took part in the paid summer internship program.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
Michael Nichols conducting NIH-funded research into chemical mechanisms that lead to brain inflammation in Alzheimer’s patients
Nichols received a $459,279 grant from the National Institute of General Medical Sciences to study the mechanisms of NLRP3 inflammasome activation.
MORE IN amyloid-β protein
LATEST NEWS
- At the Missouri Arts Council, Bob Madden helps foster community engagement and education through art
- College of Optometry using VR technology to create customized progressive lenses
- 5th annual UMSL 5K to bring alumni, community together on campus
- UMSL alum Isabelle Herman first to complete full Triton Traditions challenge
- Inaugural cohort of Scale AI employees begins UMSL geospatial certificate program
- Eye on UMSL: Global study options
- UMSL’s Beta Alpha Psi chapter earns top awards at annual national meeting
- UMSL Tritons weekly rewind
- UMSL optometry alum Dr. Brianne Hobbs named dean of Chicago College of Optometry
- New UMSL Guardian app strengthening safety across campus
